Ref ID: 18783
Author:
H. Y. Tsai, MD (Doctor of Medicine) – Infection specialist1,2, Chien-Yuan Chen, Shang-Yi Huang, Woei Tsay, Ming Yao, Jih-Luh Tang, Bo-Sheng Ko, Wen-Chien Chou, Hwei-Fang Tien, Po-Ren Hsueh;
Author address:
1Far Eastern Mem. Hosp., New Taipei City, Taiwan, 2Far Eastern Mem. Hosp., New Taipei city, Taiwan.
Full conference title:
52nd Annual ICAAC
Date: 9 September 2014
Abstract:
Background: Few studies have investigated the clinical manifestations and outcome of candidemia in patients with hematological malignancies. Methods: We retrospectively analyzed the patient presented with candidemia in adult patients with hematological malignancies during the period 2001-1 to 2010-12 at the NTUH. Susceptibility of Candida species to nine antifungal agents was determined using the broth microdilution method. Interpretive criteria for susceptibility followed the MIC breakpoints of Candida species recommended by the CLSI (M27-S3) and the EUCAST-2012. Results: A total of 154 episodes of candidemia were noted in 111 of 2,574 patients with hematological malignancies. Patients with acute lymphoblastic leukemia (ALL) had a significantly higher rate of candidemia than patients with other hematological malignancies (Odds ratio, 2.69, p<0.001). Candida tropicalis was the most common Candida species (n=52, 47%), followed by C. albicans (n=35, 32%), C. parapsilosis (n=14, 13%). Multivariate analysis revealed that shock (p<0.001), allogeneic transplantation (p=0.033), and elderly (age, ≥ 60 years, p=0.041) were independent prognostic factors of 30-day overall survival. A total of 105 non-duplicate blood isolates of Candida species (84 isolates from 82 patients without persistent candidemia and 21 isolates from 21 patients with persistent candidemia) were evaluated for in vitro susceptibility. Fluconazole, voriconazole and posaconazole resistance were found in 8%, 8% and 38% of Candida isolates, respectively.All Candida isolates were susceptible to capsofungin and 2 (14%) of the 14 isolates of C. parapsilosis were not susceptible to micafungin or anidulafungin. Conclusions: patients with ALL are at higher risk of developing candidemia than patients with other hematological malignancies. Shock, allogeneic transplantation, and elderly, are independent predictors of outcome in patients with hematological malignancy and candidemia.
Abstract Number: M-1669
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a